Stock ELV ELEVANCE HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Market Closed - Nyse
Other stock markets
 04:00:01 2024-06-05 pm EDT 		5-day change 1st Jan Change
540 USD -0.08% Intraday chart for Elevance Health, Inc. +6.82% +14.52%
Jun. 04 Sector Update: Health Care Stocks Rise Late Afternoon MT
Jun. 04 Sector Update: Health Care MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 76,584 79,856 112,508 122,511 110,797 125,508 - -
Enterprise Value (EV) 1 92,083 94,150 130,384 139,238 129,391 142,844 139,206 137,180
P/E ratio 16.4 x 17.9 x 18.7 x 20.7 x 18.7 x 15.7 x 13.7 x 12.1 x
Yield 1.06% 1.18% 0.98% 1% 1.26% 1.17% 1.25% 1.36%
Capitalization / Revenue 0.74 x 0.66 x 0.82 x 0.79 x 0.65 x 0.73 x 0.69 x 0.64 x
EV / Revenue 0.89 x 0.78 x 0.95 x 0.89 x 0.76 x 0.83 x 0.76 x 0.7 x
EV / EBITDA 11.7 x 10.1 x 13 x 12.7 x 10.7 x 10.6 x 9.45 x 8.55 x
EV / FCF 18.5 x 9.74 x 17.9 x 19.2 x 19.1 x 14.6 x 15.3 x 14.9 x
FCF Yield 5.41% 10.3% 5.58% 5.2% 5.23% 6.83% 6.53% 6.71%
Price to Book 2.48 x 2.46 x 3.17 x 3.36 x 2.85 x 2.86 x 2.49 x 2.18 x
Nbr of stocks (in thousands) 253,564 248,704 242,715 238,828 234,959 232,418 - -
Reference price 2 302.0 321.1 463.5 513.0 471.6 540.0 540.0 540.0
Announcement Date 1/29/20 1/27/21 1/26/22 1/25/23 1/24/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 103,141 120,808 136,943 155,660 170,209 171,492 182,396 195,008
EBITDA 1 7,862 9,320 10,011 10,924 12,114 13,497 14,727 16,053
EBIT 1 7,067 8,527 9,150 10,016 11,254 12,330 13,461 14,635
Operating Margin 6.85% 7.06% 6.68% 6.43% 6.61% 7.19% 7.38% 7.5%
Earnings before Tax (EBT) 1 5,985 6,238 7,925 7,769 7,715 10,557 11,851 12,875
Net income 1 4,807 4,572 6,104 6,025 5,987 8,056 9,070 9,981
Net margin 4.66% 3.78% 4.46% 3.87% 3.52% 4.7% 4.97% 5.12%
EPS 2 18.47 17.98 24.73 24.81 25.22 34.46 39.49 44.53
Free Cash Flow 1 4,984 9,667 7,277 7,247 6,765 9,763 9,090 9,204
FCF margin 4.83% 8% 5.31% 4.66% 3.97% 5.69% 4.98% 4.72%
FCF Conversion (EBITDA) 63.39% 103.72% 72.69% 66.34% 55.84% 72.33% 61.72% 57.34%
FCF Conversion (Net income) 103.68% 211.44% 119.22% 120.28% 112.99% 121.19% 100.23% 92.22%
Dividend per Share 2 3.200 3.800 4.520 5.120 5.920 6.298 6.767 7.319
Announcement Date 1/29/20 1/27/21 1/26/22 1/25/23 1/24/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 36,018 37,886 38,482 39,625 39,667 41,898 43,377 42,480 42,454 42,273 42,877 42,805 43,381 44,506 45,752
EBITDA 1 1,998 3,046 2,993 2,862 2,023 3,472 3,313 3,659 2,094 3,746 3,534 3,568 2,493 3,985 4,028
EBIT 1 1,773 2,817 2,766 2,636 1,797 3,245 3,101 3,021 1,887 3,531 3,293 3,288 2,250 3,866 3,697
Operating Margin 4.92% 7.44% 7.19% 6.65% 4.53% 7.74% 7.15% 7.11% 4.44% 8.35% 7.68% 7.68% 5.19% 8.69% 8.08%
Earnings before Tax (EBT) 1 1,400 2,326 2,143 2,146 1,154 2,619 2,441 1,654 1,001 2,939 2,905 2,851 1,928 3,429 3,342
Net income 1 1,137 1,805 1,653 1,618 949 1,989 1,853 1,289 856 2,246 2,204 2,169 1,482 2,647 2,524
Net margin 3.16% 4.76% 4.3% 4.08% 2.39% 4.75% 4.27% 3.03% 2.02% 5.31% 5.14% 5.07% 3.42% 5.95% 5.52%
EPS 2 4.630 7.390 6.790 6.680 3.930 8.300 7.790 5.450 3.630 9.590 9.452 9.287 6.404 11.49 10.90
Dividend per Share 2 1.130 1.280 1.280 1.280 1.280 1.480 1.480 1.480 1.480 1.630 1.545 1.545 1.545 1.557 1.557
Announcement Date 1/26/22 4/20/22 7/20/22 10/19/22 1/25/23 4/19/23 7/19/23 10/18/23 1/24/24 4/18/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 15,499 14,294 17,876 16,727 18,594 17,336 13,698 11,672
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.971 x 1.534 x 1.786 x 1.531 x 1.535 x 1.284 x 0.9301 x 0.7271 x
Free Cash Flow 1 4,984 9,667 7,277 7,247 6,765 9,763 9,090 9,205
ROE (net income / shareholders' equity) 16% 14.1% 17.6% 16.7% 20.8% 20.7% 20.3% 19.3%
ROA (Net income/ Total Assets) 6.45% 5.57% 6.64% 6.02% 7.43% 7.94% 8.08% 8.06%
Assets 1 74,512 82,034 91,962 100,116 80,538 101,439 112,209 123,865
Book Value Per Share 2 122.0 131.0 146.0 153.0 166.0 189.0 217.0 248.0
Cash Flow per Share 2 23.30 42.00 33.90 34.60 34.00 37.00 43.90 -
Capex 1 1,077 1,021 1,087 1,152 1,296 1,302 1,314 1,405
Capex / Sales 1.04% 0.85% 0.79% 0.74% 0.76% 0.76% 0.72% 0.72%
Announcement Date 1/29/20 1/27/21 1/26/22 1/25/23 1/24/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Elevance Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
540 USD
Average target price
607.2 USD
Spread / Average Target
+12.44%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+14.52% 126B
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-4.44% 463B
HUMANA INC. Stock Humana Inc.
-21.15% 43.5B
CENTENE CORPORATION Stock Centene Corporation
-6.08% 37.2B
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-15.17% 17.96B
PROGYNY, INC. Stock Progyny, Inc.
-26.20% 2.61B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-3.95% 1.58B
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
+16.58% 551M
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. ELV Stock
  4. Financials Elevance Health, Inc.